erythromycin has been researched along with Pleural Effusion, Malignant in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, M; Li, C; Li, T; Li, Y; Qi, Q; Wang, A; Wang, B; Xu, L; Zhang, Y | 1 |
| Bagalas, V; Balassoulis, G; Chloros, D; Kontakiotis, T; Manika, K; Patakas, D; Porpodis, K; Sichletidis, L; Spyratos, D; Zarogoulidis, K | 1 |
| Cheng, D; Tang, X | 1 |
1 trial(s) available for erythromycin and Pleural Effusion, Malignant
| Article | Year |
|---|---|
Intrapleural combination therapy with lobaplatin and erythromycin for non-small cell lung cancer-mediated malignant pleural effusion.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Cyclobutanes; Erythromycin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Pleural Effusion, Malignant; Prospective Studies; Survival Analysis; Treatment Outcome | 2018 |
2 other study(ies) available for erythromycin and Pleural Effusion, Malignant
| Article | Year |
|---|---|
Efficacy and safety of erythromycin as sclerosing agent in patients with recurrent malignant pleural effusion.
Topics: Adenocarcinoma; Aged; Anti-Bacterial Agents; Breast Neoplasms; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Drainage; Erythromycin; Female; Humans; Kidney Neoplasms; Male; Pleural Effusion, Malignant; Pleurodesis; Recurrence; Safety; Sclerosing Solutions; Treatment Outcome | 2008 |
[The value of erythromycin pleurodesis in the treatment of malignant pleural effusions].
Topics: Adenocarcinoma; Adult; Aged; Anti-Bacterial Agents; Carcinoma, Squamous Cell; Erythromycin; Female; Humans; Male; Middle Aged; Pleural Effusion, Malignant; Pleural Neoplasms; Pleurodesis | 1997 |